Congressional Affairs
Congressional Affairs
This webpage is a comprehensive, easy-to-navigate platform to enhance your understanding of DEA operations and to facilitate an ongoing collaboration with members of Congress and their staffs.
Joint Statement from DOJ, FBI, and DEA on Bringing Nicolás Maduro into U.S. Custody to Face Justice
DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care
New Rules Expand Telehealth Options for Opioid Use Disorder and Veterans’ Treatments
WASHINGTON – The U.S. Drug Enforcement Administration, in partnership with the Department of Health and Human Services (HHS), has issued a Fourth Temporary Extension of the COVID-19 Telemedicine Flexibilities for the Prescription of Controlled Medications, extending the current telemedicine flexibilities through December 31, 2026.
DEA Fentanyl Seizures in 2026
The 2026 fentanyl seizures represent over 2.3 million deadly doses. *
updated: January 15, 2026
Statements for the Record
February 1, 2023 - Statement of Associate Administrator Jon DeLena - Lives Worth Living: Addressing the Fentanyl Crisis, Protecting Critical Lifelines, and Combatting Discrimination Against Those with Disabilities
February 15, 2023 - Statement of Administrator Anne Milgram - Countering Illicit Fentanyl Trafficking
April 27, 2023 - Statement of Administrator Anne Milgram - Fiscal Year 2024 Request for the Drug Enforcement Administration
May 10, 2023 - Statement of Administrator Anne Milgram - A Review of the President’s Fiscal Year 2024 Funding Requests for the Federal Bureau of Investigation and for the U.S. Drug Enforcement Administration
June 21, 2023 - Statement of Matthew J. Strait Deputy Assistant Administrator Diversion Control Division - Responding to America's Overdose Crisis: An Examination of Legislation to Build Upon the SUPPORT Act
July 12, 2023 - Statement of Kemp L. Chester Senior Advisor, Office of National Drug Control Policy Committee on Homeland Security - Leading the Strategic Response to Disrupt the Flow of Illicit Fentanyl Across Our Borders
July 27, 2023 - Statement of Administrator Anne Milgram - Drug Enforcement Administration Oversight
October 24, 2023 - Statement of William F. Kimbell Chief of Operations Drug Enforcement Administration - Hearing Entitled, “TBD”
March 20, 2024 - Testimony of James Dunlap Deputy Under Secretary for Analysis Office of Intelligence and Analysis U.S. Department of Homeland Security - Examining the Current Status of Iran’s Axis of Resistance and the Implications for Homeland Security and U.S. Interests
April 30, 2024 - Statement of William F. Kimbell Chief of Operations Drug Enforcement Administration - Hearing Entitled, “TBD”
May 7, 2024 - Statement of Administrator Anne Milgram - Fiscal Year 2025 Request for the Drug Enforcement Administration